These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28540500)

  • 1. Effect of Relative Humidity on Bipolar Electrostatic Charge Profiles of dry Powder Aerosols.
    Yu J; Wong J; Ukkonen A; Kannosto J; Chan HK
    Pharm Res; 2017 Aug; 34(8):1707-1715. PubMed ID: 28540500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of relative humidity on the electrostatic charge properties of dry powder inhaler aerosols.
    Kwok PC; Chan HK
    Pharm Res; 2008 Feb; 25(2):277-88. PubMed ID: 17619997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring Bipolar Charge and Mass Distributions of Powder Aerosols by a Novel Tool (BOLAR).
    Wong J; Lin YW; Kwok PC; Niemelä V; Crapper J; Chan HK
    Mol Pharm; 2015 Sep; 12(9):3433-40. PubMed ID: 26222019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosol electrostatics. I: Properties of fine powders before and after aerosolization by dry powder inhalers.
    Byron PR; Peart J; Staniforth JN
    Pharm Res; 1997 Jun; 14(6):698-705. PubMed ID: 9210184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applicability of Bipolar Charge Analyzer (BOLAR) in Characterizing the Bipolar Electrostatic Charge Profile of Commercial Metered Dose Inhalers (MDIs).
    Leung SS; Chiow AC; Ukkonen A; Chan HK
    Pharm Res; 2016 Feb; 33(2):283-91. PubMed ID: 26337773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of humidity on the electrostatic charge and aerosol performance of dry powder inhaler carrier based systems.
    Young PM; Sung A; Traini D; Kwok P; Chiou H; Chan HK
    Pharm Res; 2007 May; 24(5):963-70. PubMed ID: 17377746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring charge and mass distributions in dry powder inhalers using the electrical Next Generation Impactor (eNGI).
    Hoe S; Traini D; Chan HK; Young PM
    Eur J Pharm Sci; 2009 Sep; 38(2):88-94. PubMed ID: 19559086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Exploration of Factors Affecting
    Ruzycki CA; Martin AR; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2019 Dec; 32(6):405-417. PubMed ID: 31418632
    [No Abstract]   [Full Text] [Related]  

  • 9. Particle size and charge distribution analysis of pharmaceutical aerosols generated by inhalers.
    Saini D; Biris AS; Srirama PK; Mazumder MK
    Pharm Dev Technol; 2007; 12(1):35-41. PubMed ID: 17484142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of relative humidity on electrostatic charge decay of drugs and excipient used in dry powder inhaler formulation.
    Elajnaf A; Carter P; Rowley G
    Drug Dev Ind Pharm; 2007 Sep; 33(9):967-74. PubMed ID: 17891583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of storage relative humidity on aerosolization of co-spray dried powders of hygroscopic kanamycin with the hydrophobic drug rifampicin.
    Momin MAM; Tucker IG; Das SC
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1205-1213. PubMed ID: 30990097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference in resistance to humidity between commonly used dry powder inhalers: an in vitro study.
    Janson C; Lööf T; Telg G; Stratelis G; Nilsson F
    NPJ Prim Care Respir Med; 2016 Nov; 26():16053. PubMed ID: 27853177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrostatic charge characteristics of jet nebulized aerosols.
    Kwok PC; Trietsch SJ; Kumon M; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2010 Jun; 23(3):149-59. PubMed ID: 20500092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of crystallinity on electrostatic charging in dry powder inhaler formulations.
    Wong J; Kwok PC; Noakes T; Fathi A; Dehghani F; Chan HK
    Pharm Res; 2014 Jul; 31(7):1656-64. PubMed ID: 24464269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of Electrostatic Behavior of Dry Powder-Inhaled Model Formulations.
    Jetzer MW; Morrical BD
    J Pharm Sci; 2019 Sep; 108(9):2949-2963. PubMed ID: 31004652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
    Singh DJ; Jain RR; Soni PS; Abdul S; Darshana H; Gaikwad RV; Menon MD
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):254-67. PubMed ID: 25517187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerodynamic and electrostatic properties of model dry powder aerosols: a comprehensive study of formulation factors.
    Telko MJ; Hickey AJ
    AAPS PharmSciTech; 2014 Dec; 15(6):1378-97. PubMed ID: 24938617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Spacers on the Bipolar Electrostatic Charge Properties of Metered Dose Inhaler Aerosols-A Case Study With Tilade
    Leung SSY; Chiow ACM; Kwok PCL; Ukkonen A; Chan HK
    J Pharm Sci; 2017 Jun; 106(6):1553-1559. PubMed ID: 28238902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of patients' real-life environmental temperature and humidity use conditions of tiotropium dry powder inhaler on its aerosol emission characteristics.
    Ammari WG; Mohammad MK; Tayyem RF
    Eur J Pharm Sci; 2019 May; 133():137-144. PubMed ID: 30946963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCF-engineered powders for delivery of budesonide from passive DPI devices.
    Lobo JM; Schiavone H; Palakodaty S; York P; Clark A; Tzannis ST
    J Pharm Sci; 2005 Oct; 94(10):2276-88. PubMed ID: 16136557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.